Connect Sign In
Hydroxychloroquine interferes with a virus’s ability to replicate, but that mechanism is unproven in patients with COVID-19. Small inpatient studies of the drug have thus far not been promising.
ARUP Laboratories will play a key role in a CDC-funded project that aims to reduce the risk of COVID-19 infection in hospital emergency department workers nationwide.
The David Eccles School of Business at the U and University of Utah Health announce the start of Utah HERO, an undertaking that will begin with testing 10,000 Utahns across four counties.
Laboratory employees on the frontlines of COVID-19 testing at ARUP are drawing inspiration from an unexpected source: 1,000 colorful paper cranes.
Julio Delgado, MD, MS, ARUP chief medical officer and director of laboratories, is the featured guest on the newest episode of “Silicon Slopes Live.” He discusses COVID-19 antibody testing.
In the six weeks since ARUP became the first clinical laboratory in Utah and one of the first in the U.S. to offer COVID-19 diagnostic testing, ARUP has performed more than 40,000 tests in Utah alone.
Much of the attention surrounding COVID-19 laboratory testing has focused on two primary areas: viral detection to establish diagnosis and antibody testing to assess previous exposure.
Clinicians and patients always want to know they can trust the accuracy of lab test results. This has never been more true than it is now, given the attention on COVID-19 testing.
ARUP profiles laboratorians to help celebrate the meaningful and important work medical laboratory scientists do each day to benefit patients.
ARUP announced it will begin rolling out COVID-19 antibody testing nationwide by the end of this week. IgG antibody tests help detect antibodies to SARS-CoV-2, the virus that causes COVID-19.
ARUP CEO Sherrie L. Perkins, MD, PhD, is the featured guest on the newest episode of “U Rising,” a podcast that introduces listeners to “people who are helping the U along its upward trajectory.”
Just a few months into the COVID-19 pandemic, the healthcare market is flush with COVID-19 laboratory testing platforms. This increase can make it challenging to critically evaluate COVID-19 tests.
